Sulfamethoxazole/Trimethoprim Versus Fluoroquinolones for the Treatment of Stenotrophomonas maltophilia Bloodstream Infections | Zendy

L. A. Watson | Zendy; John S. Esterly | Zendy; Michael Postelnick | Zendy; Arturo L. Aguirre | Zendy; Milena M. McLaughlin | Zendy

Open Access

Sulfamethoxazole/Trimethoprim Versus Fluoroquinolones for the Treatment of Stenotrophomonas maltophilia Bloodstream Infections

Author(s) -

L. A. Watson,

John S. Esterly,

Michael Postelnick,

Arturo L. Aguirre,

Milena M. McLaughlin

Publication year - 2015

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofv133.565

Subject(s) - stenotrophomonas maltophilia , medicine , sulfamethoxazole , trimethoprim , microbiology and biotechnology , bloodstream infection , gram negative bacterial infections , stenotrophomonas , bacteremia , antibiotics , intensive care medicine , pseudomonas aeruginosa , pseudomonas , bacteria , biology , genetics

Stenotrophomonas maltophilia Bloodstream Infections Luke Watson, PharmD1; John Esterly, PharmD1,2; Michael Postelnick, RPh1; Arturo Aguirre, BS1,3; Milena McLaughlin, PharmD, MSc1,4 Northwestern Memorial Hospital, Chicago, IL1, Chicago State University College of Pharmacy, Chicago, IL2, University of Illinois at Chicago, Chicago, IL3, Midwestern University Chicago College of Pharmacy, Downers Grove, IL4 Milena McLaughlin, PharmD, MSc Midwestern University Chicago College of Pharmacy 555 31st Street Downers Grove, IL 60515 mmclau@midwestern.edu

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research